Alder Biopharmaceuticals Lands $80,000,000 New Funding Round

  • Feed Type
  • Date
    5/8/2014
  • Company Name
    Alder Biopharmaceuticals
  • Mailing Address
    11804 North Creek Parkway South Bothell, WA 98011 USA
  • Company Description
    Alder Biopharmaceuticals (NASDAQ: ALDR) uniquely identifies, develops, and manufactures novel antibody therapeutics to alleviate human suffering in the autoimmune and inflammatory disease areas. Alder’s management team combines decades of industry experience with a proven track record for identifying and developing novel antibody therapeutics.
  • Website
    http://www.alderbio.com
  • Transaction Type
    IPO
  • Transaction Amount
    $80,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.